Combination therapy for rheumatoid arthritis

Research output: Contribution to journalReview article

Abstract

Traditionally, NSAIDs have been used in the initial treatment of patients with rheumatoid arthritis (RA). If the patient's disease progressed, then therapy was "stepped up" to use disease-modifying antirheumatic drugs (DMARDs). However, NSAIDs rarely provide appropriate monotherapy in established RA. Corticosteroids provide relief of symptoms, but they have several adverse effects. Initiation ofDMARD therapy early in the disease course has gained acceptance. Because the RA disease process has many inflammatory and proliferative pathways, multiple agents targeted at specific aspects of the immune response may provide effective therapy without increasing toxicity. Methotrexate is included in most regimens. Hydroxychloroquine and sulfasalazine are commonly used. Newer drugs that may be used in combination therapy include biologic response modifiers that target specific cytokines.

Original languageEnglish (US)
Pages (from-to)36-40
Number of pages5
JournalDrug Benefit Trends
Volume15
Issue numberSUPPL. C
StatePublished - Jun 1 2003

Keywords

  • Combination therapy
  • Corticosteroids
  • DMARDs
  • NSAIDs
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Combination therapy for rheumatoid arthritis'. Together they form a unique fingerprint.

  • Cite this